Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceuticals ranked by total assets, at DKK 1.42T, ahead of Johnson & Johnson (DKK 1.36T) and Sanofi (DKK 958.2B). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerDKK 1.42T
- Median
- DKK 24B
- Combined market value
- DKK 34.93T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | DKK 1.42T | DKK 1.1T | DKK 192.77 | 0.58% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | DKK 1.36T | DKK 4.54T | DKK 1,887.42 | 0.56% down | 38% up | ||
| 3 | SanofiSNY · Health Care | DKK 958.2B | DKK 777.8B | DKK 323.91 | 0.06% up | 4% down | ||
| 4 | Merck & CoMRK · Health Care | DKK 932.1B | DKK 2.38T | DKK 963.83 | 1.29% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | DKK 912.3B | DKK 3.5T | DKK 1,981.71 | 0.63% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | DKK 776.9B | DKK 1.91T | DKK 1,228.70 | 1.02% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | DKK 766B | DKK 8.5T | DKK 9,546.36 | 0.98% down | 35% up | ||
| 8 | NovartisNVS · Health Care | DKK 755.6B | DKK 2.02T | DKK 1,071.30 | 1.15% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | DKK 661.6B | DKK 468B | DKK 146.50 | 0.60% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | DKK 613.2B | DKK 844.5B | DKK 413.16 | 1.12% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | DKK 590.6B | DKK 1.24T | DKK 714.23 | 0.15% up | 17% down | ||
| 12 | GSKGSK · Health Care | DKK 552.5B | DKK 671B | DKK 334.74 | 0.18% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | DKK 548.7B | DKK 1.21T | DKK 273.72 | 1.25% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 277.5B | DKK 340.7B | DKK 291.97 | 0.59% up | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | DKK 276.2B | DKK 677.6B | DKK 6,550.28 | 0.42% up | 36% up | ||
| 16 | ViatrisVTRS · Health Care | DKK 253.3B | DKK 161.6B | DKK 140.94 | 1.20% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | DKK 174.6B | DKK 934.7B | DKK 3,686.55 | 1.33% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | DKK 149B | DKK 39.9B | DKK 58.57 | 0.35% down | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | DKK 133.6B | DKK 269.7B | DKK 469.11 | 0.29% up | 78% up | ||
| 20 | ZoetisZTS · Health Care | DKK 105.3B | DKK 231.7B | DKK 570.32 | 0.31% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | DKK 91B | DKK 89.6B | DKK 179.25 | 1.82% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | DKK 87.7B | DKK 217.1B | DKK 352.11 | 0.50% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 79.4B | DKK 106.2B | DKK 1,653.85 | 0.88% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | DKK 55.8B | DKK 316.1B | DKK 2,767.65 | 1.67% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | DKK 53.7B | DKK 168.3B | DKK 3,952.83 | 0.63% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | DKK 51.7B | DKK 78.2B | DKK 403.93 | 1.37% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 42B | DKK 85B | DKK 101.99 | 1.18% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | DKK 38.9B | DKK 193.1B | DKK 266.57 | 1.11% up | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | DKK 33.8B | DKK 142.3B | DKK 1,062.55 | 0.31% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | DKK 25.1B | DKK 51.1B | DKK 146.56 | 1.89% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | DKK 24B | DKK 31.1B | DKK 186.54 | 1.59% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | DKK 19.7B | DKK 34.5B | DKK 412.86 | 0.43% up | 20% down | ||
| 33 | AlkermesALKS · Health Care | DKK 16.9B | DKK 53.1B | DKK 315.70 | 1.99% up | 58% up | ||
| 34 | InsmedINSM · Health Care | DKK 15.4B | DKK 182.2B | DKK 830.41 | 0.06% up | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | DKK 11.8B | DKK 21.7B | DKK 111.90 | 1.99% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | DKK 10.6B | DKK 40.4B | DKK 2,018.52 | 0.87% up | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | DKK 9.8B | DKK 121.2B | DKK 1,847.37 | 0.02% up | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | DKK 9.7B | DKK 49.9B | DKK 358.03 | 1.78% up | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 9.4B | DKK 42.1B | DKK 297.62 | 1.65% up | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 8.6B | DKK 66.5B | DKK 2,863.17 | 0.38% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | DKK 7.2B | DKK 65.8B | DKK 435.47 | 1.96% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | DKK 6.4B | DKK 59.2B | DKK 2,117.48 | 1.92% up | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | DKK 6.4B | DKK 33.6B | DKK 193.08 | 1.80% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | DKK 6.4B | DKK 103.2B | DKK 529.59 | 1.25% up | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | DKK 5.7B | DKK 40.9B | DKK 626.68 | 0.07% up | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | DKK 5.7B | DKK 52.2B | DKK 477.32 | 0.02% up | 8% down | ||
| 47 | Belite BioBLTE · Health Care | DKK 5.3B | DKK 43.7B | DKK 1,075.67 | 0.14% up | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | DKK 5.3B | DKK 62.1B | DKK 653.68 | 2.31% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 5.2B | DKK 51.7B | DKK 657.97 | 1.58% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | DKK 5.1B | DKK 61.6B | DKK 76.98 | 5.93% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | DKK 4.7B | DKK 48.4B | DKK 919.43 | 0.70% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | DKK 4.6B | DKK 56B | DKK 857.96 | 1.05% up | 46% up | ||
| 53 | ABIVAXABVX · Health Care | DKK 4.4B | DKK 50.1B | DKK 571.85 | 2.27% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | DKK 4.1B | DKK 33.2B | DKK 345.79 | 0.64% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | DKK 3.8B | DKK 31B | DKK 283.15 | 1.11% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | DKK 3.6B | DKK 33.7B | DKK 599.13 | 1.14% up | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | DKK 3.3B | DKK 45.3B | DKK 667.50 | 1.75% up | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 3.3B | DKK 54.9B | DKK 792.31 | 0.24% down | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | DKK 3B | DKK 27.5B | DKK 201.22 | 0.56% up | 169% up | ||
| 60 | ErascaERAS · Health Care | DKK 2.7B | DKK 32.4B | DKK 92.25 | 2.48% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | DKK 1B | DKK 36.4B | DKK 863.72 | 0.94% up | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8106 DKK).
Questions and answers
Which pharmaceuticals rank first by total assets?
Pfizer (DKK 1.42T), Johnson & Johnson (DKK 1.36T) and Sanofi (DKK 958.2B) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 15:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of DKK 34.93T as of 18 Nov 2026, 15:06 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.